Evidence map›Paper›PMID 32697765›Full record

ArticleAging2020

Zhanbing Zhang, Chi Zhou, Lihua Tang, Yukang Gong, Zhiting Wei, Gongchen Zhang, Feng Wang, Qi Liu, Jing Yu

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Zhanbing ZhangDepartment of Endocrinology and Metabolism, Shanghai Tenth People's Hospital; Bioinformatics Department, School of Life Sciences and Technology, Tongji University, Shanghai 200009, China.
Chi ZhouDepartment of Endocrinology and Metabolism, Shanghai Tenth People's Hospital; Bioinformatics Department, School of Life Sciences and Technology, Tongji University, Shanghai 200009, China.
Lihua TangSchool of Geographic and Biologic Information, Nanjing University of Posts and Telecommunications, Nanjing 210023, China.
Yukang GongDepartment of Ophthalmology, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Tongji University, Shanghai 200009, China.
Zhiting WeiDepartment of Endocrinology and Metabolism, Shanghai Tenth People's Hospital; Bioinformatics Department, School of Life Sciences and Technology, Tongji University, Shanghai 200009, China.
Gongchen ZhangDepartment of Endocrinology and Metabolism, Shanghai Tenth People's Hospital; Bioinformatics Department, School of Life Sciences and Technology, Tongji University, Shanghai 200009, China.
Feng WangDepartment of Gastroenterology, Shanghai Tenth People's Hospital; Bioinformatics Department, School of Life Sciences and Technology, Tongji University, Shanghai 200009, China.
Qi LiuDepartment of Ophthalmology, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Tongji University, Shanghai 200009, China.
Jing YuDepartment of Ophthalmology, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Tongji University, Shanghai 200009, China.
Tongji University · CNShanghai Tenth People's Hospital · CNNanjing University of Posts and Telecommunications · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer neoantigens have shown great potential in immunotherapy, while current software focuses on identifying neoantigens which are derived from SNVs, indels or gene fusions. Alternative splicing widely occurs in tumor samples and it has been proven to contribute to the generation of candidate neoantigens. Here we present

Indexed as

Alternative SplicingAntigens, NeoplasmCancer VaccinesCohort StudiesComputer SimulationGenes, MHC Class IHumansImmunotherapyNeoplasmsPrecision MedicinePredictive Value of TestsRNA, NeoplasmRNA-SeqSequence Analysis, RNASurvival AnalysisAntigens, NeoplasmCancer VaccinesRNA, Neoplasmalternative splicingcancerimmunotherapyneoantigenRNA-seq

Identifiers

PMID32697765
PMCPMC7425491
OpenAlexW3045142091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.